Asset Details
Do you wish to reserve the book?
Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013
Do you wish to request the book?
Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013
2017
Overview
Geographic and racial disparities may contribute to variation in the incidence and outcomes of HIV-associated cancers in the United States.
Using the Surveillance, Epidemiology, and End Results (SEER) database, we analyzed Kaposi sarcoma (KS) incidence and survival by race and geographic region during the combined antiretroviral therapy era. Reported cases of KS in men from 2000 to 2013 were obtained from 17 SEER cancer registries. Overall and age-standardized KS incidence rates were calculated and stratified by race and geographic region. We evaluated incidence trends using joinpoint analyses and calculated adjusted hazard ratios (aHR) for overall and KS-specific mortality using multivariable Cox proportional hazards models.
Of 4,455 KS cases identified in men younger than 55 years (median age 40 years), the annual percent change (APC) for KS incidence significantly decreased for white men between 2001 and 2013 (APC -4.52, p = 0.02). The APC for AA men demonstrated a non-significant decrease from 2000-2013 (APC -1.84, p = 0.09). Among AA men in the South, however, APC has significantly increased between 2000 and 2013 (+3.0, p = 0.03). In addition, compared with white men diagnosed with KS during the same time period, AA men were also more likely to die from all causes and KS cancer-specific causes (aHR 1.52, 95% CI 1.34-1.72, aHR 1.49, 95% CI 1.30-1.72 respectively).
Although overall KS incidence has decreased in the U.S., geographic and racial disparities in KS incidence and survival exist.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
Acquired immune deficiency syndrome
/ Adult
/ Age
/ AIDS
/ Analysis
/ Cancer
/ Complications and side effects
/ HIV
/ Human immunodeficiency virus
/ Humans
/ Male
/ Medicine and Health Sciences
/ Men
/ Race
/ Research and Analysis Methods
/ Sarcoma
/ Sarcoma, Kaposi - epidemiology
/ Survival
